Results 21 to 30 of about 201,532 (165)

Angiotensin II Antagonists

open access: yesClinical and Experimental Hypertension, 1993
Acute blockade of the renin-angiotensin system with the parenterally active angiotensin II antagonist saralasin has been shown to effectively lower blood pressure in a large fraction of patients with essential hypertension and to improve hemodynamics in some patients with congestive heart failure.
Brunner HR   +3 more
openaire   +3 more sources

Angiotensin II in septic shock [PDF]

open access: yesCritical Care, 2015
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015.
Corrêa TD, Takala J, Jakob SM
openaire   +4 more sources

Role of Angiotensin Receptor Type I and Type II in the Development of Common Cardiac Problems

open access: yesJournal of the Practice of Cardiovascular Sciences
The renin–angiotensin system is crucial for maintaining blood pressure and fluid balance. Central to this system are the angiotensin receptors, type I (AT1R) and type II (AT2R), which mediate the effects of angiotensin II (Ang-II).
Tannistha Hota   +2 more
doaj   +1 more source

Angiotensin II and Renal Fibrosis [PDF]

open access: yesHypertension, 2001
Abstract — — Angiotensin (Ang) II, the main peptide of the renin angiotensin system (RAS), is a renal growth factor, inducing hyperplasia/hypertrophy depending on the cell type. This vasoactive peptide activates mesangial and tubular cells and interstitial fibroblasts, increasing the ...
Mezzano, SA, Ruiz-Ortega, M, Egido, J
openaire   +4 more sources

Angiotensin II [PDF]

open access: yesHypertension, 2008
Investigating the mechanisms of atherosclerosis, the number one cause of death in the civilized world, is an arduous task. During the last 5 decades, many aspects of atherosclerotic lesion development have been revealed and many hypotheses have been tested.
Cornelius F.H. Mueller, Georg Nickenig
openaire   +1 more source

Angiotensin Receptor Blocker (ARB): Is it Effective to Prevent Cerebral Malaria? [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases
Cerebral malaria is a severe complication of plasmodium falciparum infection with 15-25% mortality rates. Sequestration of infected red blood cells disrupts the blood brain barried leading to irreversible brain damage, impacting quality of life.
I Gusti Ayu Hiranandini Prawista   +6 more
doaj   +1 more source

Maternal plasma angiotensin 1-7 concentration is related to twin pregnancy chorionicity in the third trimester of pregnancy

open access: yesFrontiers in Endocrinology
IntroductionTwin gestation is related to a higher risk of hypertensive disorders in pregnancy with possible risk stratification depending on chorionicity.
Paweł Pietruski   +6 more
doaj   +1 more source

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer

open access: yesOncology Reviews, 2011
Angiotensin II (Ang-II) plays a key role as a vasoconstrictor in controlling blood pressure and electrolyte/fluid homeostasis. Recently it has also been shown that this peptide is a cytokine, acting as a growth factor in cardiovascular and stromal cells.
Hiroji Uemura   +2 more
doaj   +2 more sources

Angiotensin II antagonists

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2014
The angiotensin II antagonists, a new group of drugs, block in a selective way AT receptors, causing vasodilatation, increase of renin and of angiotensin II, reduction of peripheral resistance, of the aldosterone levels, and of blood pressure without ...
David García Barreto   +1 more
doaj  

Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock

open access: yesAnnals of Intensive Care, 2023
Background The physiological effects of renin-angiotensin system modulation in acute respiratory distress syndrome (ARDS) remain controversial and have not been investigated in randomized trials. We sought to determine whether angiotensin-II treatment is
Daniel E. Leisman   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy